Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „study“
Suchtreffer
Begriffe & Kennungen
Abilify Maintena · 4.8 · Data from an open-label study of patients treated with Abilify Maintena 960 mg, showed minimal change from bas
Eintrag öffnenAbilify Maintena · 4.8 · In an open-label study comparing bioavailability of Abilify Maintena 400 mg/300 mg administered in the deltoid
Eintrag öffnenAbilify Maintena · 4.8 · In an open-label, multiple-dose, randomised study in adult patients with schizophrenia (and bipolar I disorder
Eintrag öffnenAbilify Maintena · 4.8 · Injection site reactions The percentage of patients in an open-label study reporting any injection site-relate
Eintrag öffnenAbiraterone Mylan · 4.5 · In a CYP2C8 drug-drug interaction study in healthy subjects, the AUC of pioglitazone was increased by 46% and
Eintrag öffnenAbiraterone Mylan · 4.5 · In a separate clinical pharmacokinetic interaction study of healthy subjects, co-administration of ketoconazol
Eintrag öffnenAbiraterone Mylan · 4.8 · A higher incidence of hypertension and hypokalaemia was observed in the hormone sensitive population (study 30
Eintrag öffnenAblymico · 4.5 · No interaction study has been performed. A clinically relevant interaction with active substances with poor so
Eintrag öffnenAbraxane · 4.5 · A pharmacokinetic study was conducted with Abraxane and carboplatin in non-small cell lung cancer patients. Th
Eintrag öffnenAbraxane · 4.8 · The study consisted of 106 patients, 104 of whom were paediatric patients aged from 6 months to less than 18 y
Eintrag öffnenAdasuve · 4.5 · A study of inhaled loxapine and intramuscular lorazepam 1 mg in combination found no significant effects on re
Eintrag öffnenAdasuve · 4.5 · A study of inhaled loxapine and intramuscular lorazepam 1 mg in combination found no significant effects on re
Eintrag öffnenAdasuve · 4.8 · Assessment of adverse reactions from clinical study data is based on two Phase 3 and one Phase 2A short-term (
Eintrag öffnenAdasuve · 4.8 · Assessment of adverse reactions from clinical study data is based on two Phase 3 and one Phase 2A short-term (
Eintrag öffnenAdcetris · 4.8 · Combination Use Study C25004
Eintrag öffnenAdcetris · 4.8 · In the HD21 study, 747 patients received BrECADD, and 741 patients received eBEACOPP (escalated bleomycin [B],
Eintrag öffnenAdcetris · 4.8 · Monotherapy Study C25002
Eintrag öffnenAdcetris · 4.8 · Safety was evaluated in a phase 1/2 study in paediatric patients aged 7-17 years of age (n = 36) with relapsed
Eintrag öffnenAdcetris · 4.8 · The rate of ADA positivity was low in Study C25004; 4 patients (aged ≥ 12 years) of 59 patients became transie
Eintrag öffnenAdcirca (previously Tadalafil Lilly) · 4.8 · 8 In the pivotal placebo-controlled study of ADCIRCA for the treatment of PAH, a total of 323 patients were tr
Eintrag öffnen